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Ferredoxin-NADP+ reductases (FNRs, EC 1.18.1.2) were found in the plastids ofPlasmodium andhave been considered as a target for
the development of new antimalarial agents. Croomine, epi-croomine, tuberostemonine, javastemonine A, and isoprotostemonine
are isolated alkaloids from the roots of Stemona sp. and their inhibitory effect on FNRs from Plasmodium falciparum (PfFNR)
was investigated. Croomine showed the highest level of inhibition (33.9%) of electron transfer from PfFNR to PfFd, while
tuberstemonine displayed the highest level of inhibition (55.4%) of diaphorase activity of PfFNR. Docking analysis represented
that croomine is located at the middle position of PfFNR and PfFd. Croomine from S. tuberosa appeared to have potential as an
antimalarial agent.
1. Introduction
Malaria is still considered as a threat in the world, especially
in Asia and Africa. Almost 97 countries in the world are
malaria endemic. More than 3.3 billion people (almost 50%
of the world’s population) are at risk of malaria with two
Plasmodium species responsible for themajority of infections:
P. falciparum and P. vivax [1]. Many antimalarial agents,
such as chloroquine, pyrimethamine, quinine, proguanil,
sulfadoxine, and artemisinin have been used for malarial
therapy. Artemisinin, the first-line antimalarial drug has been
used against P. falciparum in Cambodia, Thailand, Vietnam,
and Myanmar, where artemisinin-resistant parasites have
already been identified [1]. In Papua, Indonesia, resistance to
artemisinin derivatives, artesunate and dihydroartemisinin,
and semisynthetic 10-alkylamino-artemisinin derivatives,
artemisone and artemiside, has also been observed in P.
falciparum [2]. Ratcliff, et al. (2007) studied 143 patients
(103 and 40 patients) who were treated with chloroquine-
sulfadoxine and chloroquine, respectively. The failure rate at
28 and 42 days was 65% and 48% for P. falciparum and P.
vivax, respectively [3]. Pyrimethamine and sulfadoxine can
inhibit dihydrofolate reductase (DHFR) and dihydropteroate
synthase (DHPS) enzymes. These enzymes undergo gene
mutations causing the resistance of antimalarial antifolate [4].
Double and quadruplemutations in theP. vivax dihydrofolate
reductase (PvDHFR) found in Papua P. vivax isolates were 46
and 18%, respectively [5].
Plasmodium sp. has a unique organelle, called apicoplast,
and it possesses metabolic pathways, which is not found
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Figure 1: Structure of alkaloids from the roots of Stemona sp.
in human host [6, 7]. The apicoplast was firstly found in
P. falciparum and Toxoplasma [8]. The function of plastid
(apicoplast) in Apicomplexa is unclear, but many studies
suggested its roles in the biosynthesis of fatty acids, haem,
isoprenoids, and Fe-S cluster, based on the analysis of genome
sequence. More importantly, the metabolism of apicoplast is
necessary for the survival of the Plasmodium [6, 9, 10].
Ferredoxin (Fd) and Fd-NADP+ reductase (FNR) in api-
coplast constitute a redox system [11, 12] that is homologous
to those of plant chloroplast and algae, especially green and
red algae [8, 13].The involvement of apicoplast Fd has been
indicated in the reactions of an Fe-S cluster assembly [14]
and isoprenoid biosynthesis pathways [10, 15], fatty acid
desaturation [5], and heme oxygenation [16].
In a previous study, in silico analysis showed that croom-
ine and epi-croomine could form hydrogen bonds with the
amino acid residue of Ala9 of the DHFR enzyme [17]. DHFR
can be found in human and Plasmodium, but FNR is found
only in Plasmodium. Fd and FNR were cloned from P.
falciparum and their interactions were characterized [9, 18].
There has been no report on plant-alkaloid inhibiting FNR
available to date. Here, we describe the inhibitory effect of
alkaloids from the roots of Stemona sp. on the PfFd/FNR
redox system, and the results of their docking analysis.
2. Materials and Methods
2.1. Isolation of Alkaloid from Stemona Species. The dry roots
of S. tuberosa were cut in small size and ground into powder
and extracted using ethanol. The filtrate was evaporated
under vacuum and extracted by acid based method using 5%
of HCl and conc of NH
4
OH. Water fraction was partitioned
using dichloromethane (DCM) and evaporated. The crude
alkaloid was separated using column chromatography under
silica gel as stationary phase and DCM-methanol as mobile
phase with polarity gradient elution. The alkaloids were puri-
fied using preparative chromatography to give tuberostemo-
nine, croomine, and epi-croomine (epi-10-hydroxycroomine
or 3-epi-tuberospironine A) [19].
Isolation of isoprotostemonine and javastemonine A
from S. javanica utilized the same method as described for
the isolation of alkaloids from S. tuberosa. Previous study
exhibited that tuberostemonine, croomine, and epi-croomine
were treated to antifolate target of DHFR enzymes. Isopro-
tostemonine and javastemonine A from S. javanica were
carried out against P. falciparummultidrug resistant and wild
type parasites at Medical Molecular Research Unit, Thailand
Science Park, Pathumthani, Thailand [20]. The structures of
alkaloids were shown in Figure 1. Five alkaloids were made
as 1000 ppm stock solution (in 0.2% of DMSO in suspension
of phosphate buffer at pH 7.0). The final alkaloids solution
concentration was 100 ppm.
2.2. Preparation of Recombinant PfFNR and PfFd. Pro-
duction and purification of recombinant PfFd and
PfFNR were performed as reported by Kimata-Ariga et al.
[9].
2.3. Enzymatic Activity Analysis. Enzyme activity of PfFNR
was measured using a grating microplate reader (model SH-
1000Lab, CORONA, Japan). Diaphorase activity of FNR with
DCPIP as an electron acceptor (Scheme 1) was measured
as reported by Onda [21] with modification in the reaction
mixture of 50 mM Tris-HCl (pH 7.5), 1 mM MgCl
2
, 0.2 mM
DCPIP, and 5 nM FNR.The reaction was initiated by adding
5-100 𝜇M of NADPH and the decrease of the absorbance
was monitored for 5 min with 10-second intervals at 600 nm.
The activity of NADPH-dependent electron transfer from
FNR to Fd (Scheme 2) was measured using cytochrome c
(cyt c) as an arbitrary electron acceptor as reported by Onda
[21] with modification in the reaction mixture of 50 mM
Tris-HCl (pH 7.5), 100 mM NaCl, 200 𝜇M cytc, and 10 nM
PfFNR. Electron transfer reaction was initiated by adding
0.5-40 𝜇M PfFd and 100 𝜇M NADPH, and the absorbance
was monitored for 5 min with 10-second intervals at 550 nm.
The kinetic parameters for the Michaelis constant (Km) for
these reactions were determined.
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Scheme 1 (NADPHaFNRa DCPIP). Scheme 1 is used for
measuring the NADPH-dependent catalytic activity of FNR.
Scheme 2 (NADPH aFNRaFd a cytc). Scheme 2 is used
for measuring the NADPH-dependent electron transfer
activity from FNR to Fd.
2.4. Inhibition Assay. Inhibition of diaphorase activity of
PfFNR was measured in the reaction of Scheme 1 as
described above, by the additions of each alkaloid at 100 ppm,
NADPH at 100 uM, and 5 nM FNR. Inhibition of the electron
transfer from PfFNR to PfFd was measured in the reaction
of Scheme 2 as described above, by the additions of each
alkaloid at 100 ppm and PfFd at 1 𝜇M. A 5 mM solution of
DMSO was used as a control.
2.5. Docking Procedures. Molecular docking was performed
using Dock 6.8 software (http://dock.compbio.ucsf.edu/
DOCK 6/index.htm) [22]. Docking studies were carried out
on an Intel Core i5 2.4 GHz PC, with 16 GBmemory and with
Windows 10 operating system.
3. Ligand and Receptor Preparations
The receptor model was obtained from Protein Data Bank
(PDB) server (http://www.rcsb.org/) with ID 1GAQ [23].This
complex consists of three chains, there are enzyme Plas-
modium falciparum (PfFNR), flavin adenine dinucleotide
(FAD), and some crystals of water. Crystals of water were
not involved in the reaction mechanism directly and were
stripped out from the complex. In contrary, FAD was used as
a part of the receptor.Hydrogen and charge atomswere added
to PfFNR and FAD complex using molecular mechanics
method with AMBERff14SB force field [24]. Hydrogen atom
was stripped out from PfFNR and hydrogen-free PfFNR was
saved in pdb format to generate molecular surface of the
receptor.
Ligand models were drawn using HyperChem6 software
of HyperCube, Inc (http://www.hyper.com/). All the ligand
models were preoptimized using MM+molecular mechanics
methods before being optimized utilizing semiempirical
method AM1 to generate 3D conformation also in Hyper-
Chem 6 as final process. These optimized ligands were saved
in MDL mol file format. Hydrogen and charge atoms were
added and loaded using the AM1-BCC charge calculation
[25] andUCSFChimera (https://www.cgl.ucsf.edu/chimera/)
[26] methods, respectively. All these protonated and charged
ligands were saved in Sybil mol2 files format.
4. Ligands Docking
The molecular surface of the receptor was generated with
the dms tools which was included in the DOCK 6.8 package
program. The molecular surface was achieved by dms tool
and spheres of the receptor were generated using program
sphgen [27]. Binding site was represented by the largest clus-
ter of the spheres generated of sphgen. Grid box for docking
simulation was created around the binding site with extra
margin 5 A˚. Grid spacewas set in 0.2A˚, while the dimension is
Figure 2: Selected cluster sphere of the receptor as the representa-
tion of the binding site is inside the grid box.
Table 1: Inhibition (%) of NADPH-dependent catalytic activity of
PfFNR.
Alkaloids ∗ dA/dt∗∗ % Inhibition
Control 0.059 -
Croomine 0.039 33.9
Epi-croomine 0.059 0.7
Tuberstemonine 0.052 11.5
Isoprotostemonine 0.088 -48.8
Javastemonine A 0.065 -9.5
∗Each of alkaloids is 100 ppm; ∗∗dA/dt is the rate of absorbance change.
47.814A˚ x 63.571A˚ x 39.732A˚.The location of the largest cluster
of the spheres as the representation of the binding site and
grid box on the receptor was shown in Figure 2. Each ligand
was docked within the binding site of the receptor using
Dock 6.8 resulting in binding (Grid score) and van derWaals
(Grid vdw) energies, electrostatic interaction (Grid es), and
internal energy of the complex (Int energy). Int energy was
determined based on force of field energy calculated.
5. Results and Discussion
The structures of alkaloids from the roots of Stemona species
are shown in Figure 1.
5.1. Inhibition of NADPH-Dependent Catalytic Activity of
PfFNR by Alkaloids from the Stemona sp. The effect of these
alkaloids from the roots of Stemona spp. (Figure 1) on the
NADPH-dependent catalytic activity (diaphorase activity) of
PfFNR (Table 1) was inquired. In this reaction, the effects on
the FNR catalytic activity and/or interaction with NADPH
were to be considered. In the absence of the inhibitors,
the Km value for NADPH was 3.57 𝜇M. The inhibition
assay was performed under the same conditions used in the
Km determination employing the following conditions: the
concentration of NADPH was 100 𝜇M, the concentration of
PfFNRwas 5 nM, and the concentration of tested compounds
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Table 2: Inhibition of diaphorase activity of PfFNR.
Alkaloids∗ dA/dt∗∗ % Inhibition
Control 0.139 -
Croomine 0.138 0.7
Epi-croomine 0.122 12.2
Tuberstemonine 0.062 55.4
Isoprotostemonine 0.17 -22.3
Javastemonine A 0.144 -3.6
∗Each of alkaloids is 100 ppm; ∗∗dA/dt is the rate of absorbance change.
was 100 ppm. The % inhibition was calculated according to
the following equation, and the results are listed in Table 1.
% Inhibition = (
𝑑𝐴/𝑑𝑡) 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 − (𝑑𝐴/𝑑𝑡) 𝑠𝑎𝑚𝑝𝑙𝑒
(𝑑𝐴/𝑑𝑡) 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
× 100%
(1)
The results showed that three out of the five tested
compounds were able to inhibit the reaction by between
0.7 and 33.9%, while the other two compounds exhibited
a negative inhibition, which means that these compounds
accelerated the activity. Croomine alkaloid showed 33.9%, the
largest inhibition, and epi-croomine showed lower but con-
siderable inhibition. Isoprotostemonine and javastemonineA
exhibited a negative inhibition. This might be because both
alkaloids have double bonds conjugated to carbonyl group
and, thus, might considerably trigger electron delocalization
and stabilisation of resonance. Stabilisation of resonance
in isoprotostemonine and javastemonine A, which means
that these compounds accelerated the electron transfer from
PfFNR to PfFd, will make P. falciparum parasites live because
electron transfer occurs in respiratory process [28].
5.2. Inhibition of the Electron Transfer from PfFNR to PfFd by
Alkaloids from the Stemona sp. The effect of alkaloids from
the roots of Stemona sp. (Figure 1) on the electron transfer
from PfFNR to PfFd (Table 2) was investigated. In the
absence of the inhibitors, the Km value of PfFNR for PfFd
was 0.56 𝜇M, which was consistent with previous studies
[28]. The inhibition assay was performed under the same
conditions used in the Km determination employing the
following conditions: the concentration of PfFdwas 1 𝜇M, the
concentration of PfFNR was 10 nM, and the concentration
of tested compounds was 100 ppm. The % inhibition was
calculated according to (1) and the results are listed in Table 2.
In this case, the same three compounds inhibited the
reaction, while the two compounds exhibited a negative
inhibition, but to different extents as compared to the results
in Table 1. Croomine showed the largest inhibition on the
reaction the FNR activity and tuberstemonine showed slight
inhibition. This could be due to the inhibition of either
FNR catalysis or NADPH binding to FNR. Croomine was
previously shown to inhibit the activity of dihydrofolate
reductase (DHFR, an enzyme for antifolate drug mecha-
nism). The IC
50
of croomine to the DHFR was 5.29 𝜇M,
while tuberostemonine was not active to the enzyme [17].
Ramli et al. (2015) reported that isoprotostemonine and
javastemonine A have low to in active against multidrug
resistant K1CB1 and wild type and antifolate strains of P.
falciparum parasites in vitro [20]. On the other hand, isopro-
tostemonine and javastemonine A showed negative inhibi-
tion and they accelerated FNR reaction. The javastemonine
A exhibited moderate activities against P. falciparum TM4
and KI strains with IC
50
of 17.7 and 16.8 ppm, respectively
[20].
The diaphorase activity of PfFNR in the presence of the
Stemona alkaloids at 100 ppm is shown in Table 2. In this case,
tuberostemonine alkaloids showed the highest inhibition
and epi-croomine showed slight inhibition. Tuberostemo-
nine could inhibit electron transfer process of PfFNR to
PfFd enzyme. Isoprotostemonine and javastemonine A again
exhibited a negative inhibition, because both alkaloids have
double bonds conjugated to carbonyl group. Isoprotostemo-
nine and javastemonine A could be considered as trigger
electron delocalization and stabilisation of resonance.
5.3. Docking Analysis of Alkaloids toward Protein. The inter-
action between the alkaloids from the Stemona sp. and PfFd-
PfFNR was studied by molecular docking. The structure of
PfFNR was obtained from the Protein Data Bank (PDBID
1GAQ)[23]. Five alkaloids from Stemona sp. were expected
to bind to PfFNR. Figure 2 showed the location of the largest
cluster of the spheres as the representation of the binding site
and grid box on the receptor. This result indicated that the
parameters used in the procedure could be extended to search
for the binding conformation to the active site for the other
ligands (alkaloids). Figure 3 showed that interaction between
receptors of PfFd (blue), PfFNR (brown), and ligand (red).
FAD (green) is not involved in bonding receptors-ligand.
Electron transfer is going on in Plasmodium from PfFNR
to PfFd through electrostatics interaction during respiration
process [9]. Position of croomine displayed at the middle
betweenPfFNR and PfFd, while epi-croomine, tuberostemo-
nine, isoprotostemonine, and javastemonine A were on the
edge of the receptors (Figure 3). Croomine showed inhibition
33%, which was higher than tuberostemonine and epi-
croomine. Croomine could obstruct electron transfer from
PfFNR to PfFd. This result was supported by research report
foregoing that croomine inhibited competitively the human
DHFR enzyme at 10 ppm [17].
Tuberostemonine is stenine alkaloid, while croomine
and epi-croomine are spironine, and isoprotostemonine and
javastemonine A are stemoamide alkaloids types [29]. The
characteristic of stenine type is 4-fused rings in its structure,
and spironine type has only 2-fused rings. N atom in 4-fused
rings structure is rigid and stable. It is likely that the N atom
in 4-fused ring is important for the diaphorase activity.
6. Conclusions
Croomine could inhibit the activity of FNR enzyme and
electron transfer from PfFNR to PfFd. Thus, croomine from
S. tuberosa appeared to have potential as an antimalar-
ial agent. Tuberostemonine inhibited diaphorase for redox
reaction.
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Figure 3: Interaction between receptors of Fd (blue), FNR (brown), and ligand (red): (a) croomine, (b) Epi-croomine, (c) tuberstemonine,
(d) isoprotostemonine, and (e) javastemonine A.
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